Triptorelin patch - Pantec Biosolutions

Drug Profile

Triptorelin patch - Pantec Biosolutions

Alternative Names: IVF-001

Latest Information Update: 05 Apr 2016

Price : $50

At a glance

  • Originator Pantec Biosolutions
  • Class Antineoplastics; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Female infertility

Highest Development Phases

  • Phase I Female infertility

Most Recent Events

  • 01 Apr 2016 Triptorelin patch is available for licensing as of 01 Apr 2016. http://www.pantec-biosolutions.com
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top